Запис о доказима методе

Adaptive Phase IV study

An Adaptive Phase IV study is a post-marketing surveillance study conducted after a drug or intervention has received regulatory approval, augmented with pre-specified adaptive design elements that allow pre-planned modifications to the study protocol in response to accumulating data. These modifications may include sample size re-estimation, endpoint adjustments, or population enrichment, all governed by statistical rules set before the study begins, preserving scientific integrity while increasing efficiency.

Sources recorded, not reviewed

Изворни запис

Цитирани радови су копирани дословно из изворног записа методе. Из њих се не изводи верификација на нивоу тврдње.

Adaptive Phase IV Post-Marketing Study

Таксономски запис методе · process-pipeline / epidemiology

Chow, S. C., & Chang, M. (2008). Adaptive Design Methods in Clinical Trials. Chapman and Hall/CRC. · ISBN 978-1584889625
U.S. Food and Drug Administration. (2019). Adaptive Designs for Clinical Trials of Drugs and Biologics: Guidance for Industry. FDA. · URL

Отвори пуну методу

Куроване тврдње

Тврдње су сачуване у регистру доказа, свака са својом проценом.

Још увек нема курованих тврдњи

Овај приказ не измишља процену тврдње када регистар нема ниједну.

Сродне методе

Генерисано из графа метода и приказано као машински предложене везе — не изводи се тврдња доказа.

Taxonomic bucketAdaptive Phase III clinical trialmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketAdaptive Randomized Clinical Trialmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketBayesian Phase IV studymachine-suggested · Relational suggestion, not evidence.Taxonomic bucketCohort Studymachine-suggested · Relational suggestion, not evidence.Taxonomic bucketPhase IV studymachine-suggested · Relational suggestion, not evidence.Taxonomic bucketPragmatic phase IV studymachine-suggested · Relational suggestion, not evidence.